Element Science

Overview
News
Wearable Tech?
Product stageSegments
Go-to-Market
?
Wearable medical devices
?

Element Science is an innovative health technology company pioneering a digital wearable platform for high-risk cardiovascular patients. Their flagship product, the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD), is a novel, water-resistant wearable defibrillator designed to detect and treat life-threatening arrhythmias in patients with a temporarily elevated risk for sudden cardiac arrest (SCA). The Jewel continuously monitors a patient's heart and treats specific life-threatening rhythms, enabling continued protection during normal daily activities, including showering, sleeping, and moderate exercise.

The device incorporates advanced machine learning algorithms, an approach commonly used in consumer wearables but relatively uncommon in medical device development. The Jewel Mobile App enables timely patient care by transmitting therapy information to the patient's medical team in near real-time. The effectiveness of the Jewel defibrillator was confirmed in the Jewel EP Lab Study conducted in Prague, Czech Republic in January 2023, where 16 patients experiencing ventricular arrhythmias were successfully converted to a normal heart rhythm after a single therapeutic shock.

The Jewel IDE Study, a pivotal study of 305 patients presented at the American Heart Association's 2023 Annual Scientific Sessions in November 2023, demonstrated significant patient compliance and protected time, resulting in a high number of successful patient saves and no deaths or serious adverse events related to the device. The Jewel P-WCD has received the European Union's CE mark certification and Great Britain's UKCA marking as of January 2024, validating the device's development, testing, and clinical results.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
200 Kansas Street Suite 210 San Francisco CA USA
Founded year:
2011
Employees:
101-250
IPO status:
Private
Total funding:
USD 183.1 mn
Last Funding:
USD 145.6 mn (Series C; Mar 2020)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.